Market Brief Cable Clobbered BYND Busted
See a summary of the top themes and trends that FX and Equity traders were watching in today's US session!
Share this:
- FX: It was a quiet day in the FX market…with the massive exception of the worst day of the year for sterling. The UK currency fell sharply as government officials upped their game of chicken with the European Union, leading traders to conclude that the odds of a no-deal Brexit are rising.
- President Trump tweeted that “The Fed has made all of the wrong moves” and that “a small rate cut is not enough” ahead of Wednesday’s highly-anticipated monetary policy meeting. Separately, former Fed Chairwoman Yellen endorsed a rate cut this week but stated that she “wouldn’t see [it] as the beginning… of a major easing cycle.”
- Commodities: Both gold and oil traded higher on the day.
- US indices closed mixed on the day, with the Dow edging out a small gain, while the S&P 500 and tech-heavy Nasdaq 100 each ticked lower.
- Defensive Utility (XLU) and Health Care (XLV) sectors led the way, while Financials (XLF) were the weakest sector.
- Stocks on the Move:
- Beyond Meat (BYND) reported better-than-expected revenue and boosted its full-year outlook, but the stock did miss EPS estimates (-$0.24 vs. -$0.08 expected). The stock is trading lower in after-hours trade, following a 5% drop during today’s business hours.
- Pfizer (PFE, -4%) agreed to merge its off-patent drug business with Mylan (MYL, +13%)
- FX: It was a quiet day in the FX market…with the massive exception of the worst day of the year for sterling. The UK currency fell sharply as government officials upped their game of chicken with the European Union, leading traders to conclude that the odds of a no-deal Brexit are rising.
- President Trump tweeted that “The Fed has made all of the wrong moves” and that “a small rate cut is not enough” ahead of Wednesday’s highly-anticipated monetary policy meeting. Separately, former Fed Chairwoman Yellen endorsed a rate cut this week but stated that she “wouldn’t see [it] as the beginning… of a major easing cycle.”
- Commodities: Both gold and oil traded higher on the day.
- US indices closed mixed on the day, with the Dow edging out a small gain, while the S&P 500 and tech-heavy Nasdaq 100 each ticked lower.
- Defensive Utility (XLU) and Health Care (XLV) sectors led the way, while Financials (XLF) were the weakest sector.
- Stocks on the Move:
- Beyond Meat (BYND) reported better-than-expected revenue and boosted its full-year outlook, but the stock did miss EPS estimates (-$0.24 vs. -$0.08 expected). The stock is trading lower in after-hours trade, following a 5% drop during today’s business hours.
- Pfizer (PFE, -4%) agreed to merge its off-patent drug business with Mylan (MYL, +13%)
Latest market news
The complete CFD trading experience
Award-winning platforms, competitive spreads, low commissions and dedicated support.
We live and breathe the markets and are dedicated to helping traders realise their ambitions as we continue to set the industry bar.
Economic calendar
Web Trader platform
Our sophisticated web-based platform is packed with features.
Related articles
EUR/USD Q4 2026 Outlook: Euro at a Crossroads as Fed, ECB Tighten 9 25 2026
EUR/USD enters Q4 at a pivotal inflection point as competing Fed-ECB policy paths and persistent inflation risks collide with major technical support.
USD/JPY Q4 2026 Outlook: Hawkish Fed Pricing Clashes With Intervention Risk
The year-end tug-of-war is clear: hawkish Fed pricing supports USD/JPY, while intervention risk limits the upside.
Japanese Yen Forecast: USD/JPY 4% Rally Challenges Post-Intervention Downtrend 9 24 2026
USD/JPY momentum has shifted sharply higher, putting a major resistance confluence in focus as U.S. and Japanese event risk builds.
StoneX Europe Ltd may make third party material available on this website which may contain information included but not limited to the conditions of financial markets. The material is for information purposes only and does not contain, and should not be construed as containing, investment advice and/or investment recommendation and/or an investment research and/or an offer of or solicitation for any transactions in financial instruments; any decision to enter into a specific transaction shall be made by the client following an assessment by him/her of their situation.
StoneX Europe Ltd makes no representation or warranty and assumes no liability as to the accuracy or completeness of the information provided, nor any loss arising from any investment based on a recommendation, forecast or other information supplied. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. We are not under any obligation to update any such material. Any opinion made may be personal to the author and may not reflect the opinion of StoneX Europe Ltd.